Related Experiment Videos
Nephrectomy in renal carcinoma with distant metastasis
T Onishi1, T Machida, F Masuda
1Department of Urology, Jikei University School of Medicine, Tokyo, Japan.
British Journal of Urology
|June 1, 1989
Summary
For renal carcinoma with metastasis, nephrectomy is effective in only 27% of cases. Pre-operative evaluation of clinical measurements and metastasis extent is crucial for deciding on nephrectomy necessity.
Area of Science:
- Oncology
- Nephrology
- Clinical Medicine
Background:
- Renal carcinoma with distant metastasis presents a significant clinical challenge.
- Prognosis for patients with metastatic renal carcinoma is often poor, necessitating evaluation of treatment efficacy.
Purpose of the Study:
- To evaluate the effectiveness of nephrectomy in patients with renal carcinoma and distant metastasis at diagnosis.
- To identify clinical factors predicting survival in metastatic renal carcinoma patients undergoing nephrectomy.
Main Methods:
- Retrospective analysis of 96 patients with metastatic renal carcinoma.
- Classification into groups based on nephrectomy status and survival post-nephrectomy.
- Assessment of six clinical measurements (hemoglobin, ESR, alpha 2 globulin, temperature, weight, C-reactive protein), performance status, number of metastatic organs, metastatic lesions, and tumor growth rate.
Main Results:
- Nephrectomy was effective in only 27% of the studied cases.
- Survival for 1 year or more post-nephrectomy was associated with abnormalities in ≤3 clinical measurements, performance status of 0 or 1, and metastasis to a single organ.
- Patients surviving 3 years or more exhibited significantly slower metastatic lesion growth.
Conclusions:
- Nephrectomy effectiveness in metastatic renal carcinoma is limited.
- Pre-operative assessment of specific clinical measurements and metastatic burden is critical for surgical decision-making.
- Careful patient selection is paramount to optimize outcomes in metastatic renal carcinoma.